Hannah Holdstein

Hannah Holdstein has extensive work experience in various roles and industries. Hannah is currently working as the Vice President of Product Development at Coherus BioSciences since April 2022. Prior to this, they worked at TherapeuticsMD as the Vice President of Business Development & Corporate Strategy from an undisclosed period to April 2022, and previously as the Director of Business Development from an undisclosed period to 2021. Hannah also holds the position of Director of Market Development at Phreesia from an undisclosed period to 2019. Hannah has experience in investment banking, having worked as an Investment Banking Associate at MTS Health Partners, L.P. from an undisclosed period to 2018, and as an Investment Banking Summer Associate at Morgan Stanley in 2015. Hannah Holdstein started their career as a Consultant and later Associate Consultant at Axia Ltd., a global consulting firm that was acquired by Accenture Strategy in April 2015. Their roles at Axia were from an undisclosed period to 2014 and from 2010 to 2012, respectively.

Hannah Holdstein earned a Master of Business Administration (MBA) in Finance from The Wharton School from 2014 to 2016. Prior to that, they attended The Tuck School of Business at Dartmouth in 2009 for a Bridge Program. Hannah also studied Biology at Brown University and attended Bancroft School, although specific dates and degrees for these institutions were not provided.